Clinical Trials Browser

Phase 2 × OTHER × prexasertib × Clear all

NCT06597565 2025-10-20

A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT02873975 2022-10-21

A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency

Phase 2 Completed

27 enrolled 13 charts

Classical hematology

Fanconi Anemia